Neurology Clinic, Department of Pediatrics, Maulana Azad Medical College (University of Delhi) and associated Lok Nayak Hospital, 2, BSZ Marg, Delhi, 110002, India.
Indian J Pediatr. 2020 Oct;87(10):781-786. doi: 10.1007/s12098-020-03315-x. Epub 2020 May 26.
To compare the efficacy of oral paracetamol and oral ibuprofen for the management of acute headache in children with migraine without aura.
This randomized-controlled trial was done at the Pediatric department of a public hospital in India between 20 May, 2017 and 22 March, 2018, and enrolled children (aged 6-12 y) with Migraine without aura as per International Classification for Headache Disorders, 3rd edition (ICHD-3) criteria. The 50 patients (21 females, mean age 9.9 y) consecutively enrolled were randomized by block randomization to two study groups, with one group (n = 25) receiving oral paracetamol (15 mg/kg/dose) and the other group (n = 25) oral ibuprofen (10 mg/kg/dose), at home, during a single episode of acute migraine headache. The study drugs were dispensed in a blinded fashion. Pain-freedom (score of zero in a 0-10 Visual analogue pain scale) and Pain-relief (≥2-point reduction from the baseline) two-hours after the study drug intake were the primary outcomes. Side-effects to the study drugs were actively solicited. Non-parametric tests for paired data were used.
The two groups were similar at baseline. Forty-three children (22 paracetamol group and 21 ibuprofen group) completed the study. Both pain-freedom (32% vs. 28%, P = 0.77) and pain-relief (80% vs. 80%, P = 0.86) were not significantly different between the Paracetamol and Ibuprofen groups, respectively. Ten (23.2%) children had a side-effect due to the study drug, with no significant difference between the groups (13.6% vs. 33.3%; P = 0.11).
Both paracetamol and ibuprofen are effective and safe for the treatment of acute migraine attacks in children.
比较口服扑热息痛和布洛芬治疗无先兆偏头痛儿童急性头痛的疗效。
本随机对照试验于 2017 年 5 月 20 日至 2018 年 3 月 22 日在印度一家公立医院的儿科进行,纳入符合国际头痛疾病分类,第 3 版(ICHD-3)标准的无先兆偏头痛儿童(6-12 岁)。连续纳入的 50 例患者(21 例女性,平均年龄 9.9 岁)按区组随机分为两组,一组(n=25)给予扑热息痛(15mg/kg/剂),另一组(n=25)给予布洛芬(10mg/kg/剂),在家中单次急性偏头痛发作时服用。研究药物以盲法方式发放。用药后 2 小时疼痛缓解(0-10 视觉模拟疼痛量表评分为 0)和疼痛缓解(基线降低≥2 分)为主要结局。主动征集研究药物的不良反应。采用配对数据的非参数检验。
两组基线相似。43 例儿童(扑热息痛组 22 例,布洛芬组 21 例)完成了研究。两组疼痛缓解率(32% vs. 28%,P=0.77)和疼痛缓解率(80% vs. 80%,P=0.86)均无显著差异。10 例(23.2%)儿童因研究药物出现不良反应,两组间无显著差异(13.6% vs. 33.3%;P=0.11)。
扑热息痛和布洛芬对儿童急性偏头痛发作均有效且安全。